Triton has demonstrated improvements in maternal and surgical care through earlier recognition of hemorrhage, timely intervention, and appropriate transfusions.

Triton was cleared through the U.S. FDA De Novo and 510(k) pathways and has significant clinical evidence supporting its accuracy and precision.